VRTX

NasdaqGS

VERTEX PHARMACEUTICALS INC / MA

$443.97

+0.60% today

filing 2026-05-15 · 33d behind

Price

hover · 1 move explained

4 buys77 sells2 8-K

Market cap

$114581.73M

Float

253.0M

100% public

Short % float

Pro

Days to cover

Pro

AI BriefPro

Plain-English read on VRTX's signals — what's in favor and the red flags.

Unlock with Pro

Analyst · 29

Buy

$548.69+23.6%Street target

$330.00target range$641.00

Earnings

Beat 3 of last 4

+6.3%

2025-06

+4.9%

2025-09

-2.3%

2025-12

+3.8%

2026-03

Type	Date	Insider	Title	Shares	Price	Value
Sell	2026-05-19	Bozic Carmen	EVP and CMO	1,354	$453.45	$614.0K
Sell	2026-05-19	Bunnage Mark E.	EVP, Chief Scientific Officer	33	$453.45	$15.0K
Sell	2026-03-03	Bozic Carmen	EVP and CMO	2,329	$480.31	$1.12M
Sell	2026-03-03	Kewalramani Reshma	CEO & President	400	$479.75	$191.9K
Sell	2026-03-03	Kewalramani Reshma	CEO & President	120	$481.50	$57.8K

Sell

Bozic Carmen

EVP and CMO · 2026-05-19

$614.0K

1,354 @ $453.45

Sell

Bunnage Mark E.

EVP, Chief Scientific Officer · 2026-05-19

$15.0K

33 @ $453.45

Sell

Bozic Carmen

EVP and CMO · 2026-03-03

$1.12M

2,329 @ $480.31

Sell

Kewalramani Reshma

CEO & President · 2026-03-03

$191.9K

400 @ $479.75

Sell

Kewalramani Reshma

CEO & President · 2026-03-03

$57.8K

120 @ $481.50

161 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →